Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 have?
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 has 63 citations in the OpenAlex counts ScholarIQ stores.
When was Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 published?
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 has 2020 year in the ScholarIQ index.
What is the open-access status of Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19?
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 has gold oa status in the ScholarIQ index.
What is the DOI of Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19?
The DOI for Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 is on the source record.
What is the PMID of Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19?
The PMID for Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 is on the source record.
What is the OpenAlex record for Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19?
The OpenAlex for Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 is on the source record.